4.5 Review

Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities

期刊

CURRENT OPINION IN CHEMICAL BIOLOGY
卷 54, 期 -, 页码 45-53

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2019.10.007

关键词

Activity-based protein profiling; Bacteria; Microbiome

资金

  1. National Institutes of Health [R01 EB026332, R01 EB026285]
  2. Stanford ChEM-H Chemistry/Biology Interface Predoctoral Training Program [T32 GM120007]
  3. Stanford Molecular Pharmacology Training Grant [T32 GM113854]
  4. Stanford Graduate Fellowship
  5. A.P. Giannini Foundation

向作者/读者索取更多资源

Activity-based protein profiling (ABPP) is a robust chemoproteomic technique that uses activity-based probes to globally measure endogenous enzymatic activity in complex proteomes. It has been utilized extensively to characterize human disease states and identify druggable targets in diverse disease conditions. ABPP has also recently found applications in microbiology. This includes using activity-based probes (ABPs) for functional studies of pathogenic bacteria as well as complex communities within a microbiome. This review will focus on recent advances in the use of ABPs to profile enzyme activity in disease models, screen for selective inhibitors of key enzymes, and develop imaging tools to better understand the host-bacterial interface.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

A protease-activated, near-infrared fluorescent probe for early endoscopic detection of premalignant gastrointestinal lesions

Joshua J. Yim, Stefan Harmsen, Krzysztof Flisikowski, Tatiana Flisikowska, Hong Namkoong, Megan Garland, Nynke S. van den Berg, Jose G. Vilches-Moure, Angelika Schnieke, Dieter Saur, Sarah Glasl, Dimitris Gorpas, Aida Habtezion, Vasilis Ntziachristos, Christopher H. Contag, Sanjiv S. Gambhir, Matthew Bogyo, Stephan Rogalla

Summary: Fluorescently labeled probes show great potential for clinical application in highlighting gastrointestinal lesions, providing fluorescence-guided surveillance and enhancing histopathological analysis by highlighting areas of dysplasia as small as 400 microns, even in tissues with severe inflammation and ulceration.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Chemistry, Medicinal

Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19

Kas Steuten, Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, Scott Lovell, Oguz Bolgi, Berati Cerikan, Christopher J. Neufeldt, Mirko Cortese, Ryan K. Muir, John M. Bennett, Ruth Geiss-Friedlander, Christoph Peters, Ralf Bartenschlager, Matthew Bogyo

Summary: Two proteases produced by the SARS-CoV-2 virus play essential roles in viral replication, but inhibitors may also affect host cells; careful assessment of the selectivity of protease inhibitors is needed during drug development to avoid unnecessary interference with redundant pathways for viral entry.

ACS INFECTIOUS DISEASES (2021)

Article Chemistry, Multidisciplinary

Chemiluminescent Protease Probe for Rapid, Sensitive, and Inexpensive Detection of Live Mycobacterium tuberculosis

Brett M. Babin, Gabriela Fernandez-Cuervo, Jessica Sheng, Ori Green, Alvaro A. Ordonez, Mitchell L. Turner, Laura J. Keller, Sanjay K. Jain, Doron Shabat, Matthew Bogyo

Summary: FLASH is a fast, luminescent, and affordable sensor developed for detecting and monitoring drug susceptibility of Mycobacterium tuberculosis (Mtb). It is selective for the Mtb protease Hip1 and can detect low amounts of Mtb cells with high sensitivity within minutes. FLASH can distinguish live from dead cells and has the potential to enhance TB diagnostics and drug resistance monitoring in resource-limited settings.

ACS CENTRAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

Activity-Based Diagnostics: Recent Advances in the Development of Probes for Use with Diverse Detection Modalities

Ryan K. Muir, Matteo Guerra, Matthew M. Bogyo

Summary: This review highlights recent methodologies employed in activity-based diagnostics for detecting various diseases by leveraging the dysregulated enzyme expression and activity. These methods exhibit exquisite signal sensitivity and specificity in complex biological systems, and some have advanced into clinical trials.

ACS CHEMICAL BIOLOGY (2022)

Editorial Material Biochemical Research Methods

Uncovering an overlooked consequence of phosphorylation: change in cysteine reactivity

Markus Lakemeyer, Matthew Bogyo

NATURE METHODS (2022)

Article Oncology

A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection

Gregory T. Kennedy, David E. Holt, Feredun S. Azari, Elizabeth Bernstein, Bilal Nadeem, Ashley Chang, Neil T. Sullivan, Alix Segil, Charuhas Desphande, Eric Bensen, John T. Santini Jr, John C. Kucharczuk, Edward J. Delikatny, Matthew Bogyo, A. J. Matthew Egan, Charles W. Bradley, Evgeniy Eruslanov, Jason D. Lickliter, Gavin Wright, Sunil Singhal

Summary: This study successfully translated a cathepsin activity-based probe (VGT-309) for fluorescence-guided surgery and conducted human research. The results showed that VGT-309 has good specificity and feasibility, and it can successfully label tumors during tumor resection.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Formulation of a Thermosensitive Imaging Hydrogel for Topical Application and Rapid Visualization of Tumor Margins in the Surgical Cavity

Ethan Walker, Daan G. J. Linders, Eric Abenojar, Xinning Wang, Hans Marten Hazelbag, Marieke E. Straver, Okker D. Bijlstra, Taryn L. March, Alexander L. Vahrmeijer, Agata Exner, Matthew Bogyo, James P. Basilion, Brian Straight

Summary: A formulation of a fluorescent molecular probe has been developed to enhance the resection quality for solid-tumor cancers. This formulation can be topically applied immediately after surgery and activates in the presence of residual cancer, providing a strong fluorescent signal to precisely delineate any remaining cancer cells. The utilization of this formulation has the potential to reduce re-excisions and improve patient quality of life.

CANCERS (2022)

Article Chemistry, Analytical

Covalent Library Screening by Targeted Mass Spectrometry for Rapid Binding Site Identification

Jim Nonomiya, Ke Sherry Li, Brett M. Babin, Melinda M. Mulvihill

Summary: Interest in covalent drug discovery has increased following the success of covalent inhibitors targeting BTK and KRAS G12C approved by the FDA. High-throughput screening by intact protein mass spectrometry is commonly used to identify lead compounds, but it does not provide binding site information. This article introduces CoMPAS, a new targeted mass spectrometry-based covalent screening method that provides binding site information in the initial screen and offers advantages such as higher sensitivity and reduced protein reagent requirements.

ANALYTICAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Chemoproteomic identification of a DPP4 homolog in Bacteroides thetaiotaomicron

Laura J. Keller, Taylor H. Nguyen, Lawrence J. Liu, Brianna M. Hurysz, Markus Lakemeyer, Matteo Guerra, Danielle J. Gelsinger, Rachael Chanin, Nhi Ngo, Kenneth M. Lum, Franco Faucher, Phillip Ipock, Micah J. Niphakis, Ami S. Bhatt, Anthony J. O'Donoghue, Kerwyn Casey Huang, Matthew Bogyo

Summary: In this study, serine hydrolases specific to the Bacteroidetes phylum were identified in the gut commensal Bacteroides thetaiotaomicron. Two of them were predicted to be homologs of the human dipeptidyl peptidase 4 (hDPP4). Functional studies showed that BT4193 is a true homolog of hDPP4 and can be inhibited by FDA-approved type 2 diabetes medications targeting hDPP4, while the other one is a misannotated proline-specific triaminopeptidase. The results also indicated that BT4193 is important for envelope integrity and fitness of B. thetaiotaomicron in a diverse bacterial community, independent of its proteolytic activity.

NATURE CHEMICAL BIOLOGY (2023)

Article Chemistry, Multidisciplinary

Structure of Staphylococcus aureus ClpP Bound to the Covalent Active-Site Inhibitor Cystargolide A

Astrid Illigmann, Marie-Theres Vielberg, Markus Lakemeyer, Felix Wolf, Taulant Dema, Patrik Stange, Wolfgang Kuttenlochner, Elisa Liebhart, Andreas Kulik, Nicole D. Staudt, Imran Malik, Stephanie Grond, Stephan A. Sieber, Leonard Kaysser, Michael Groll, Heike Broetz-Oesterhelt

Summary: The caseinolytic protease, known as a crucial enzyme in protein homeostasis, shows promising potential as a target for antibacterial and anticancer drugs. The discovery of cystargolides as the first natural beta-lactone inhibitors of the proteolytic core ClpP opens up new possibilities for research in this field. The inhibition of ClpP by cystargolide A and B is demonstrated through different biochemical methods, and further experiments confirm the specificity of ClpP as a target in Staphylococcus aureus cells.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Biochemistry & Molecular Biology

Identification of covalent inhibitors that disrupt M. tuberculosis growth by targeting multiple serine hydrolases involved in lipid metabolism

Brett M. Babin, Laura J. Keller, Yishay Pinto, Veronica L. Li, Andrew S. Eneim, Summer E. Vance, Stephanie M. Terrell, Ami S. Bhatt, Jonathan Z. Long, Matthew Bogyo

Summary: The increasing incidence of antibiotic-resistant Mycobacterium tuberculosis infections is a global health threat. In this study, researchers screened a narrow-spectrum inhibitor that successfully suppressed the growth of Mycobacterium tuberculosis. Analyses revealed that the inhibition of SH enzymes was linked to defects in cell envelope biogenesis. It was also found that resistance was primarily developed through the synthesis of mycocerates rather than mutations to SH targets.

CELL CHEMICAL BIOLOGY (2022)

暂无数据